collins just said about nih's role in general. i think we've had a history of a strong willingness to share, and think that's increased over past years. we're at a stage when we are dealing in part with technical feasibilities of

then, i use nih as the example. one thing we have been able to do in the subcommittee and senate is to prioritize our spending. it is making decisions on where to spend money, not just always the thing that many kansans think, spending more money on everything. dr. collins give me the townhall description of how successful our spending has been in the year since we last met. dr. collins: i would love to give that description. they you for the opportunity. be thing i would say, may the most important discovery that happened in the last year, is one we do not know about yet. it was a basic science discovery time, at theat the time come interesting. but we did not realize until a euro to --a year or two, how profound that was. when i was discovered, nobody had it on the list. another big discovery that we could probably mention for anybody across the table, would be something that has just happened in the more therapeutic applications. of a little boy walking around hanging on the monkey bars after being diagnosed with

look for to hearing more about nih plan when we turn to the questions. please administration in fiscal year 2019 budget abandoned its ill-conceived proposal to drastically cut grant support funding their proposed last year but troubled that now seeks to arbitrarily/researchers hours by 20% but the budget claims this proposal will stretch plant dollars to fund more research but like the previous proposal it is finally destructive and short on details, a gimmick not meant to be taken seriously. i see the budget follows congress lead by preserving the increase provided to address opioid addiction and spur the development of nonaddictive pain treatments. these are critical investments of great importance to the members of the subcommittee and i think i can speak for all of us in saying we expect the nih to ask use those resources to address this crisis. we, and those represent, are counting on you on this one. finally, few agencies enjoy greater trust and the national institute of health so it was particularly troubling the questions have been raised about t

then i use nih as the example. one of the things that we've been able to do in this subcommittee and the senate is to prioritize our spending so it's making decisions about where to spend more money not just always the thing that i think mane kansasness think happening around here. give me the up to hall description of how successful our spending has been in the year since we last met. >> i love to give that description. thank you for the opportunity. one thing that i would say is maybe the most discovery that happened in the last year is one we don't know about net because it was a basic science discovery that seemed at the time interesting but we didn't realize until maybe a year or two from now just how pro to under it mate be, we talked about crisper cass earlier. when that was discovered nobody had it on their list of the big deal from that year. another dis discovery that we could mention for anybody across this table would be something that has just happened in the more therapeutic applications in my opening

nih director dr. francis collins talked about a study whether moderate alcohol consumption's helps cardiovascular health. the program was suspended recently after some reports on the alcoholic beverage's role in the study. senator roy blunt cheers the senate subcommittee -- chairs the senate subcommittee hearing. >> [laughter] >> the appropriations subcommittee on labor, health and human services, education and related agencies will come together. glad to have our friends from nih here today, dr. collins and the institute directors. the recent support of medical research by our subcommittee and congress is clear. during the three years senator maria cantwell i worked together i workedor murray and together, $7 billion above what we were three years ago. we traveled the alzheimer's research amount, started the precision mesu medicine initiative and confident resources to such revolutionary projects as the universal flu like vaccine and a renewed canstment in nih has and provide millions of americans an

are you doing anything to make sure this is, hasn't compromise studies elsewhere in nih? >> i'm very concerned that this might be the tip of a larger iceberg, and that's part of the reason that i pulled together this very distinguished group of experts to look at it. we will look closely to see if there are other examples of this sort, because that would be very much against the principles that we stand for which is separation of funding sources from outside with decisions about science and also, of course, our peer review process ought to be above reproach as far as conflicts. i would be glad to report back to you, but this is one of my roles as the ning ih director. when we find something that has gone awry, we don't just assume it's a little thing that you can put a band-aid on. we make sure that we aim to fix those. >> thank you very much. and thank you, mr. chairman. >> senator alexander. >> thank you, mr. chairman. first, let me say to chairman blunt and to senator murray, senator durbin, all the members of the committee how much i appreciate their leadership in the

the nih certainly makes more of an effort as mr.harris was saying to address these issues like reproducibility and the new criteria with grant review where these issues are addressed within the past year now with grant review with the new criteria but all bets are off if you are privately funded science is this big step back or representing a bigger proportion of science happening now? or that it is paying attention? there are medical and legal implications they could and that being privately owned with the super wealthy and also to address at the political level with the agenda wealthy have and science could be pushed in certain directions with a personal agenda. >> we call that a compound question. [laughter] that is a is a nice one to nwr ask each author to speak to it. >> in my experience i welcome philanthropy whether from an individual or the foundation for autism researcher doing top drawer stuff and to my knowledge they are hands-off they want. one -- secure and the best scientists looking by a large and don't think billiona

the next is the nih funding, $37 billion a year.lots of associations and things like that, a minor share of total funding, and research at universities, if it is funded by drug companies and need to be mindful where funding comes from to make sure these are grants, research trying to expand knowledge and not trying to promote a particular product or whatever so we journalists think about where the money is coming from and a study in the new england journal of medicine. was affronted by drug company, important things to bear in mind. there is also philosophical biases that come in as well, choosing not to believe various things in science not just for economic reasons but maybe philosophical reasons. if climate change means the government has to have a heavier hand in the way we regulate things and people don't like the government's heavy-handed they will say i don't believe in climate change. it is important not to get sidetracked or think only about the financial conflicts but be aware of other conflicts that everyone comes to, wit

we do that at nih today. we have programs on violence and gun violence research at nih, as you know, because you appropriate the money. nih is much more open for peer review funding of -- >> my question is -- >> the cdc is not that way. we're very directed in where the money goes there. >> but can't you reprogram -- if this is a priority for you, i believe that you can reprogram or transfer funds directly for that reason. >> i would have to look into that. >> if you could do that and get back to me. >> will do. >> or are you intending to include gun violence research funding in your next budget mission? >> that would be a matter between the department and omb. i couldn't comment on where we will be as an administration. >> would you will willing to ask about that? >> i cannot reveal my deliberative work with the -- >> would you please. >> i appreciate your concern there. >> thank you. >> thank you, senator murray. the record -- and thank you for being here. the record will stay hope for one week for additiona

first of all nih. the budget before us is a 6 billion-dollar reduction in nih funding.i would indicate to my colleagues in sherman that we ought to continue our efforts in finding ways to fund nih at increasing rates and without reductions. in a broader sense i think we have focused on who's going to pay for healthcare is compared to how can we make it less expensive. how do we shift on affordable health care to someone it's still unaffordable for. seems to me the underlying cause of why it's expensive is where we ought to focus. nih in my view is one of those things. not only does it improve the quality of life and longevity, if we can find the delay to the onset of alzheimer's or eliminate cancer, reduce diabetes, they all have a cost consequence. regard to the cdc, i would advocate for continued funding of the global health fund. one thing that was sent recently from omb was that ebola has been taking care of, no reports of ebola, there were were two reports from congo shortly thereafter. regardless of reports of ebola, we need to continue to have the funding for inf

nih is opening national enrollment for this program which aims to enroll one million americans. this is the largest health research effort of its kind ever mounted on earth. it works previous longitudinal studies. everything, data on all of us will provide unprecedented levels of information about determinants of health. with this data, we can explore new frontiers of prevention and treatment for americans of all backgrounds. all of us will set a new standard for interactions between researchers, medical professionals and participants. cognizant of the great responsibility nih is taking on, this program aims to work together with all of our partners to inform the program' s directions, goals and principles. in particular the hard work of building trust among populations historically underrepresented. there will be significant benefits to these efforts. enrolling more than one million americans will enable nih to sample communities that have historically been underrepresented in current research. be the most diverse collection of data. think of your typical health study as being

first of all, nih. the budget that is before us is a $6 billion reduction in nih funding. i would indicate to my colleagues and certainly to the ranking member and chairman of this committee that we ought to continue our efforts in finding ways to fund nih at increasing rates and certainly without reductions. i think in a broader sense i think we as a congress for a long time have focused on who is going to pay for healthcare as compared to how can we make healthcare less expensive. the focus is how do we shift unaffordable healthcare to someone else who it's still unaffordable for. so it seems to me that the underlying cause of why healthcare is expensive is where we ought to focus and you are doing that and i appreciate that and nih in my view is one of those things not only does it improve people's quality of life and longevity, it's wonderful for families. if we can find the delay to onset of alzheimer's, if we can eliminate cancer, reduce diabetes, all those things have a tremendous cost consequence and we ought to be pursuing them. in regard to the cdc, i would advoc

you are the 16th director of the nih. the only person who was appointed by two different presidents. you were initially by president obama and then subsequently by president trump. as a person who co-discovered the human genome, was it harder to discover the human genome or be appointed by two different presidents? dr. collins: [laughter] i guess both of those had certain challenges associated. i did not expect to still be in this position after january 2017 because i knew about the history too. nih directors appointed by the president virtually always have turned over when there is a new president. somehow they made a mistake here, i guess, and kept me on. david: so did president trump say he knew you did a great job, or how did that come about? dr. collins: i got a call saying we want you to come to new york and meet with trump at trump tower a few days before the inauguration so that he can talk to you and get a sense of whether you are somebody he might want to keep on, so i went. david: so you went to trump tower? dr

nih funding has made that a priority over the last three years. generally, but we know about the human genome. euro body has a lot of what you need to fight off. they take a pill every day to enhance back. i think it's an important time. i think he's a great person. >> do you see the president's plans as more of an administration play affecting regulatory structure. >> a lot of the drug pricing is driven by the biggest purchaser of drugs, which is the federal government. minimal how much of that requires medicare and medicaid changes as much as it requires changes. the president laid this out as a campaign promise. i'm sure like a lot of campaign promises, it's a lot more complicated than you would think. it doesn't work out quite that well or that easily. i think they happen to put a team together for those two agencies. hhs and h a a, that would be likely to get something significant. they have a responsibility to publicly report about it as well as privately. >> you mentioned your work with the hearing today, nih. an election year. you and i bo

again, $7 billion increase in nih research after 12 years of not one penny. but it's such an unbelievable time to be doing that. i think all four of us, i think that would be fair to say that tom and i virtue said this is going to be our priority. i think all four of us have come to the conclusion that this is the right time to do this, and that house and senate things work. i think the regular dynamic though is so out of what was traditional, you know, the idea you have a a conference commit, almost unheard-of now. everything, everybody in this room would've learned in their civics class or in their early how a bill becomes a law, almost none of that happens now. the house passed a bill, the senate passed the bill, they go to conference and try to come up with a compromise that goes back to both bodies. and we have fallen into this terrible moment that i i beliee we may be about to get out of where people would actually run for office a if i don't get exactly what i want, i'm not going to be part of anything else, which is a guaranteed definition that you're

the budget request for the nah -- nih in 2019. >> sunday night, barbara ehrenreich with her book, natural causes, which explores how the body ages and dies. she is interviewed by new york times science reporter natalie enter. >> that's one of the jobs of being all his passing the torch, taking what you know and have done and want done and passing it on to younger hands. watch afterwards at 9:00 p.m. eastern on c-span twos book tv. the house has been working on the farm bill this week. one of the amendments to the bill they debated would have changed the sugar program. it was offered i virginia foxx. conaway led the opposition to the amendment. the current subsidies in programs on sugar should be maintained. we will show the debate. a formal vote is expected friday. >>

from nih to the virginia and others trying to solve the problem. they come to help us to learn to make it happen. in order to just talk about it nobody ran for congress campaigning on that. it's one of the most essential things that will happen. we spend $80 billion per year in technology. 80% goes to legacy programs. we have allowed people to keep more of that money to modernize and move forward. it was not easy to get through. we eventually had to put it into a defense bill to get signed. doesn't matter where you come from in life, there's an opportunity for you to help your government. a lot of people say did i start out to run for office? no. i grew up in a small town in bakersfield. i got out of high school and my folks and have much money so i went to a community college. i made a guy that owns a liquor store but is a car dealers license. i talk him into taking me to the l.a. car option and i start buying and selling cars and flipping them. now, it's illegal but i don't know that. so what do you do you go visit your buddies as i go to the gro

>> the nih gives each participant an unique identifying number to use instead of their name.n top of that, the program is protected by a law that keeps all the information protected from anything other than research, even law enforcement. >> why do they need so many people? why a million people? >> the more people you have, more specific information about the condition. with precision medicine research, it's a numbers game. >> dr. john torres, thank you very much. very interesting. >>> there's growing concern about the health of our water. specifically, how chemical fertilizer runoff is causing massive algae blooms in some areas but how do you stop it or control it? that's the challenge in new initiative called the water prize that comes with big bucks for the team that finds the answer. here's our chief environmental affairs correspondent ann thompson. >> reporter: on a canadian marsh, a wave of ocean blue shipping containers is the venue for a kind of water olympics. nine international teams vying for $10 million if they can stop harmful algae blooms caused by agricultural

the director of the nih tells us why he thinks it will transform health care. >>> plus -- >> reportere call it the perfect wave, and he's surfing it about 100 miles from the nearest coastline. how is that possible? world champion surfer kelly slater will show you coming up on "cbs this morning." >>> and ak tresz samira wiley tells us about her role in "the handmaid's tale." that's the "cbs morning news" for this thursday. thanks for watching. i'm anne-marie green. have a great day. -- captions by vitac -- www.vitac.com have a great day. -- captions by vitac -- www.vitac.com new mexico i'm kenny choi. >>> a live look outside at the coit tower, the city of san francisco, the dawn of a new day. it's thursday so it's almost the weekend. it is thursday, may 3rd, i'm kenny choi. >> i'm michelle griego. >> i was thinking about the weekend since monday morning when the alarm went off. >> we can dream about it more now. >> we are doing all right. >> yeah. >> it's going to be a nice day again this afternoon. get ready this morning, waking up to cloud coverage and cool along the water. so if you

philosopher and medical ethicist that's what he is a medical ethicist first of all i got that right the nih yeah well that's of ethics is a branch of philosophy and ethics deals with questions of values and the norms that we have to articulate our values and this is a prospective that is genuine in that it doesn't reduce to what empirical science can tell us and it's very valuable to have this perspective today with all the technology and science around us can we reduce it to a number though someone's life how much is my life worth for example well that's what insurance companies have to do but you wouldn't put a number on your life's worth what you. paid of interesting sions and actually our life is. most valuable asset if you want to call it such and that's why that's why i would do almost anything and want other people to do almost anything in order to save our lives or prolong on us but when it comes to some of this medication i wouldn't be able to afford it i mean people in developing countries wouldn't be able to afford it at all. how how do these big companies justify that well the b

with the nih increase, in the vest 3 years, we ha combined 32 programs. we zeroed a bunch of them out. they weren't doing what they were supposed to be doing to prioritize at this unique moment. we have a $7 billion increase in nih research. it is such an unbelievable time to be doing that. i think all four of us, i think it would be fair to say that this is going to be our priority. i think all four of us have come to the conclusion that this is the right time to do this. i think the regular dynamic is so out of what was traditional there, the idea you have a conference committee, almost unheard-of now. everybody in this room would have learned in their civics class on how a bill comes to law, none of that happens. the house passes a bill, the senate passes a bill, then they , try to come up with a compromise that goes back to both of these. we have fallen into this terrible moment. run forople would office, saying if i do not get what i want, i will not be a part of anything else. which is a guaranteed definition that you are going to fail. in a democra

and then let put it up to the nih let's hear from you because you are so far the you have been allowed to be all or. how significant that when the prime minister stands up to them they back they have an agreement in the sand which we find on except what we said you're not signing up and it had to be changed the e.u. said it couldn't be changed it was changed they said they wanted legal text by march when the prime minister saw the legal tech she said no way and they said we can't move on she said tough i'm not signing up and they backed down again they said then that they wanted it fixed by june and again it hasn't and will be fixed by june with the french foreign minister going to june is able to transfer our foreign minister isn't doing the negotiation at the moment so you know it is quite clear and the prime minister should learn from this. i don't take any dictation from the stand up to them thank your feet and and they will give in when the white paper is revealed in a few weeks time will we be able to tell whether she has been played as it were well i don't know what's going to b

news the program contains a number of radical economic proposals we spoke to a representative of the nih likely center right coalition we came to the point where the final contract that is included in the most important things from the two parts we need this to come down also the country and be able to state into the you know in a strong way we are. very focused on. democracy three that. we respect our alliances we want to be part of the e.u. . being stronger as italy. just going up to court three here in moscow now and still ahead this hour with the roll wedding in windsor under way the world's media is pouring over the ceremony at the moment as we speak but we'll be taking an alternative look just after the break. join me every thursday on the alex salmond show and i'll be speaking to us from the world of politics sports business i'm sure business i'll see you there. we have to judge countries and leaders directives. so we need more objective but the reality. try to get the facts but leave. your worldview so this is where social media and direct communication comes in unfortunately it'

i met with the washington white house fellows, they are in all different agencies, from nih to v.a. to others trying to problem, and they come from it at a different approach to help us to be able to learn to make it happen. problem, and they come from it at a different approach to help us to be able to learn to make it happen. we talked about the modernizing government act. nobody ran for congress campaigning on that, but it is probably one of the most essential things that will happen in the short time period. we spent $80 billion a year on technology. 80% of that goes to legacy programs. what we have done is we allow people to keep more of that money to modernize and move forward. this is steny hoyer and myself working on this. we eventually had to put it in the defense bill, but it will get signed and that will make a fundamental difference. does not matter where you come from in life, there is an opportunity to help your government. a lot of people sit back and say that i start out to run for office? no. no teacher that have me ever thought i could win anything. i growth in a s

. >> what about the facebook issue, and other data breaches, how does the nih protect the information that perhaps a w million peopl give them? >> from the examples that you just gave, we know that nothinga is completel. everything can be hacked. however they have taken extraordinary precautions to protect this, in their reservoirs of data. they also are assuring you thatc never be used in a law enforcement situation. it can never be used in a judicial situation. they -- congress passed a law, heth the eye towards this database of -- andve included these certificates of confidential. even if thisoes online, law enforcement can't usit. >> sreenivasan: just weeks after the golden state kilsir was caught dna evidence right? >> that is. people will have to make their own decisions. it is a personal comfort situation. some people say to themselves, i iogive qua personal informto facebook every day and what do i get? i get ads and i can be on facebook. if they want my whole genome and give me back information, that may worth it. medical records, we're talking about my genome, my activities,

they are in all different agencies of nih to the va to others trying to solve the problems and they come from a different approach to help us to be able to learn to make it happen. talking about the modernizing government act. nobody ran for congress campaigning on not, but it's probably one of the most essential things that will happen in the short time period. we spend $80 billion a year on technology. 80% of that goes to legacy programs. so what we've done is allowed people to keep more of that money to modernize and move forward. this is will hurd, steny hoyer myself working on the spirit it wasn't easy to get through. we eventually had to put in a defense bill to get signed and that would make a fundamental difference. it doesn't matter where you come from in life. as an opportunity for you to help your government. people sit back and say that i start out to run for office? no. so i grew up in a small town of acres still get a happen to be republican could my family are all democrats. i got out of high school. no one will simulate a college. my folks on how much money so i go to com

then i think you could wipe out the discretionary budget, nih and parks and the like, but i can't see any other budgetary real estate. i know my time is almost -- almost up. can you give me some examples for other possibilities than what i mentioned. >> look at the figure it gives you some idea of where the buckets are, but each that is sort of underestimating the problem because that's just the interest cost. that's just getting a deficit down towards zero. we then have a huge amount of debt sitting out there. so i think the problem is even more extreme than that. >> well, i'm not going to pummel this any longer and you have certainly made a very good point with respect to the debt, but when the growth projections are nowhere near what was promised, number one, middle class aren't seeing what they were told they were going to get which was a $4,000 pay raise and the middle class drives 70% of the american economy, i don't see how growth is going to get you close to paying for that $1.9 trillion that was put on the credit card and it still leaves us with the safety net and defense, un

american heart association, the american medical association, the american academy of pediatrics, the nih, usda, department of health and human servicess. on and on. you have the consensus on this side who has looked at science and pretty recently. or you could look at a couple of rogue scientists and companies who have a stake in the answer coming out in a way that runs contrary to what the science shows. >> well it kind of gets us into that conversation of conflict of interest versus bias. and i think a lot of times the food industry suffers because they have -- i have a financial conflict of interest because i'm running a study for a company. and that gets disclosed. but what doesn't necessarily disclose -- get disclosed are individual biases. so my love in life and anthincinan purple pigment in blue berries. i have never taken on a company on these those. but i have a bias there but that doesn't get out there whether in the media or the scientific community or within policy. and i think when you look at groups like the american heart association, well go back to sodium that's an easy

the cdc, nih, fda, dea, drug czar, prosecutors, treatment people, all aspects of the problem, and one big four-day meeting. the seventh in a row, annual summit. and the enthusiasm there for what you are doing on the drug problem was palpable. so i'm here to tell you that, from all aspects the of the problem, treatment, prosecution or research and whatever, the three-pronged effort that you are, the government is spearheading is the right way to go. cutting off the supply of illicit drugs, reducing demand here at home, and then treatment for those who are addicted. that's the proven way. and you are on to it, and you are elevating the issue publicly, and that's all important. there is still a stigma that people have attached to addiction, even though science says that it's a disease. the head of the nih that deals with drugs tells us that there are physical changes in the brain with addiction making it a disease, which we have to treat it that way. but we've made some progress on reducing the prescription pill abuse some. not much. in my state and my district, quite a bit. but it's bei

but the nih fund is $30 billion a year, so what can we do to actually create change in science with our work? and so we really took a step back and really thought, beyond resources, what else to mark and i bring to this work? with that we thought about our day job of who we are. and for me that was being a schoolteacher and a pediatrician. having been on the front lines with families and children, and realizing that you really need to be there on the front lines to understand what the real barriers and problems are. and that incredibly innovative solutions already exist on those frontlines. they are just often one-offs that don't have the opportunity to scale and reach many. and i have been lucky enough in many ways to be partnered with mark, and he brings the lens of a technologist. he built a career in building great tools that scaled to reach many. we took those lenses together and get to a couple of core values that we think about at czi. we want to stay close to the problem. we have the luxury and patience to invest for the long term, and we also know that collaboration -- will beo

prepare and stockpile something that may happen in a couple years so the conclusion we came to at the nih and cdc we have to think in terms of seasonal flu all in the same bucket you need to get a vaccine against that part that doesn't change from season to season because the vaccines we have now, even the good ones even mostly against the part of the virus will completely change with the pandemic so just a few miles north of here leading experts all over the world and in the country to develop the pathway to the universal flu vaccine so the journal of infectious diseases and then what was identified there were multiple components of the influenza virus that generally was not changed one that we have been focusing on is a particular component of a very important protein in the human virus this is a grown-up model and if you look at the top which is called the head, those red dots are mutations so if you do have that mutate season to season that is why every season essentially you have to get a new vaccine. when it really changes that vaccine will not be good but look at the dark blue that

the conclusion we came to at the nih and cdc, is we need it all in the same bucket. you need a vaccine against that part of the virus that does not change from season to season. the vaccines we have now, even the good ones, are made mostly against the part of the virus that tends to drift from season to season and completely change with a pandemic. we put a meeting together in rockville just a few miles north of here, bringing experts from all over the world and the country to develop what we call a pathway to a universal flu vaccine. we published a strategic plan and the journal of infectious diseases at the end of february. finally that was identified are multiple components of the influenza virus that generally do not change. one of the ones we have been focusing on is a particular component of a very important protein in the influenza virus called the chemo -- h emagglutinin protein. at the top, the head, the red dots are places where there are mutations. if you have that mutating season to season, that is the reason why every season you have to essentially get a

he rescheduled the time so hubert could get his nih cancer treatments. number two, he took him in the oval office and sat him behind a chair, hubert, you belonged here. and number three, remarkably, helicoptered him up to camp david, spent the day with him at camp david and humphrey told me, believe it, first time i ever have been to camp david even though i was vice president for four years. he had a wonderful relationship. hubert's loss, lost us liberal support. i really think that if hubert had lived, it would have been much more difficult for kennedy to mount what was very divisive challenge. >> very, very interesting. ira, did you have a question? ira shapiro, the one and only. >> thanks. it is actually more of a comment unsurprisingly. six years ago i wrote a book about the senate, last great senate, coincidentally, those years were the carter years. and i was surprised to find that the relationship between carter and congress, which started out rather badly, actually changed in the three years, the last three years. so that carter, carter didn't l

we had to figure out what those priorities are in think we have them and you know, with the nih increase, in the last three years, we have eliminated a combined 32 programs. zeroed a bunch of them out and they all had really good names. just were not given what they had to do to prioritize at this unique moment, again, a $7 billion increase in research after 12 years of not one penny. but as such an unbelievable time to be doing that and i think all four of us, would be fair to say i think tom and i the first year, this will be our priority. i think all four of us come to the conclusion that this is the right time to do this and the house and senate were selecting the regular dynamic is just so out of what was traditional. the idea that you have committee, almost unheard of now. everything that, everybody in this room would have learned in their civics class or in their early, how a bill becomes a law. almost none of that happens. house passed the bill, the senate passed a bill, they go to conference and trying to come up with a compromise. it goes back to both bodies and we have fallen

nih director is standing by in bethesda, maryland, to talk about the new project to prevent and treatormation will be . >> announcer: this morning's "eye opener" at 8:00 brought to you by progressive. making it easy to bundle your home and car insurance. >>> a professional surfers is working to make his sport more accessible. carter evans rode the waves to learn now. >> some people call this the perfect wave and he's surfing it 100 miles from the nearest coastline. kelly slater will show you, coming up on "cbs this morning." how is that possible? world surfer kelly slater will show you coming up on "cbs this morning." because stuffed animals are clearly no substitute for real ones. feel the clarity and live claritin clear. the toothpaste that helps prevent bleeding gums. if you spit blood when you brush or floss you may have gum problems and could be on the journey to much worse. help stop the journey of gum disease. try parodontax toothpaste. ♪ metastatic breast cancer is relentless, but i'm relentless too. mbc doesn't take a day off, and neither will i. and i treat my mbc with new e

crisis we've paid for drugs and the research that's been done privately by the drug companies or by the nih, university research, all the rest of that. and i'm happy to see the world benefiting from that. >> so am i. >> but yet as we're now entering into this period where there's increasing conflict between our country and china, we're seeing that there's discussion of tariffs going on such products that include, you know, intellectual property including the drugs. could you talk a little bit about why, you know, why those would particularly be targeted for tariffs -- >> yeah. >> -- and what the impacts of those tariffs might be. >> pharmaceuticals or biomedical, the chinese have put up something called project 2025. they've identified ten key industries that they want to be world leaders in. both in terms of satisfying their own market, but in satisfying global markets. and they are pumping subsidies, they are stealing intellectual property from american companies. when american companies invest in china, they require it to be done through a joint venture so you transfer your know-how and

we subsidize it as taxpayers and nih funding, so all sorts of inequities have to be addressed. >> neil utilities can raise prices for their customers. are we going to go that route? >> massachusetts said in their medicaid program we're not going to say to expensive drugs you're going to be in our medicaid program. we're going to knock out expensive drugs and go towards generics. will other states follow, in medicaid programs to say we'll have cheaper drugs in our system. >> neil: wouldn't you be leery of that as well? they're taking out of the system potential life-saving drugs for which there is not a generic equivalent. >> that's true. it's mandating competition in some way as well. we want to have the market be as quote, unquote, open as possible and we want everybody to have free markets and open competition but we're doing it almost by kind of executive chaos, making them do that. when you mix the formulas together economically, i'm not sure how that all turns out in ge.>> i think that's why this regulatory piece is important. people tend to overlook it. we have an fda that was de

glad to have our friends from nih here today, dr. collins and the institute directors. the recent support of medical research by our subcommittee and congress is clear. during the three years senator maria cantwell i worked together --